CAAS CAPITAL MANAGEMENT LP - ELIEM THERAPEUTICS INC ownership

ELIEM THERAPEUTICS INC's ticker is and the CUSIP is 28658R106. A total of 36 filers reported holding ELIEM THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
CAAS CAPITAL MANAGEMENT LP ownership history of ELIEM THERAPEUTICS INC
ValueSharesWeighting
Q4 2021$785,000
-41.8%
75,0000.0%0.02%
-29.6%
Q3 2021$1,349,00075,0000.03%
Other shareholders
ELIEM THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
BML Capital Management, LLC 1,938,263$5,097,6324.68%
RA Capital Management 13,150,849$34,586,7330.68%
SILVERARC CAPITAL MANAGEMENT, LLC 121,110$318,5190.10%
Atom Investors LP 78,886$207,4700.05%
DRIEHAUS CAPITAL MANAGEMENT LLC 811,680$2,134,7180.03%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 55,223$145,7890.00%
Chicago Partners Investment Group LLC 12,806$32,7850.00%
TUDOR INVESTMENT CORP ET AL 29,704$78,1220.00%
NORTHERN TRUST CORP 11,182$29,4090.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of ELIEM THERAPEUTICS INC shareholders